242 related articles for article (PubMed ID: 31609624)
1. How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions.
You Q; Sokolov M; Grigartzik L; Hintz W; van Wachem BGM; Henrich-Noack P; Sabel BA
Mol Pharm; 2019 Dec; 16(12):5068-5075. PubMed ID: 31609624
[TBL] [Abstract][Full Text] [Related]
2. Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles.
You Q; Hopf T; Hintz W; Rannabauer S; Voigt N; van Wachem B; Henrich-Noack P; Sabel BA
J Drug Target; 2019 Mar; 27(3):338-346. PubMed ID: 30280953
[TBL] [Abstract][Full Text] [Related]
3. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
4. In vivo visualisation of nanoparticle entry into central nervous system tissue.
Henrich-Noack P; Prilloff S; Voigt N; Jin J; Hintz W; Tomas J; Sabel BA
Arch Toxicol; 2012 Jul; 86(7):1099-105. PubMed ID: 22422342
[TBL] [Abstract][Full Text] [Related]
5. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; MailÀnder V
ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
[TBL] [Abstract][Full Text] [Related]
6. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.
Bagad M; Khan ZA
Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668
[TBL] [Abstract][Full Text] [Related]
7. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.
Kulkarni SA; Feng SS
Pharm Res; 2013 Oct; 30(10):2512-22. PubMed ID: 23314933
[TBL] [Abstract][Full Text] [Related]
8. In vivo MRI assessment of bioactive magnetic iron oxide/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration.
Tzameret A; Ketter-Katz H; Edelshtain V; Sher I; Corem-Salkmon E; Levy I; Last D; Guez D; Mardor Y; Margel S; Rotenstrich Y
J Nanobiotechnology; 2019 Jan; 17(1):3. PubMed ID: 30630490
[TBL] [Abstract][Full Text] [Related]
9. Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization.
Zhang E; Zhukova V; Semyonkin A; Osipova N; Malinovskaya Y; Maksimenko O; Chernikov V; Sokolov M; Grigartzik L; Sabel BA; Gelperina S; Henrich-Noack P
Eur J Pharm Biopharm; 2020 May; 150():131-142. PubMed ID: 32151727
[TBL] [Abstract][Full Text] [Related]
10. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
Kim H; Robinson SB; Csaky KG
Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
12. Exploring the systemic delivery of a poorly water-soluble model drug to the retina using PLGA nanoparticles.
Zhang E; Osipova N; Sokolov M; Maksimenko O; Semyonkin A; Wang M; Grigartzik L; Gelperina S; Sabel BA; Henrich-Noack P
Eur J Pharm Sci; 2021 Sep; 164():105905. PubMed ID: 34116175
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
15. Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats.
Chung CY; Yang JT; Kuo YC
Biomaterials; 2013 Dec; 34(37):9717-27. PubMed ID: 24034503
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
Girotra P; Singh SK
Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
[TBL] [Abstract][Full Text] [Related]
17. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
18. Comparison between Polybutylcyanoacrylate Nanoparticles with Either Surface-Adsorbed or Encapsulated Brain-Derived Neurotrophic Factor on the Neural Differentiation of iPSCs.
Lin MH; Chung CY; Chen KT; Yeh JC; Lee TH; Lee MH; Lee IN; Huang WC; Yang JT
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621332
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
[TBL] [Abstract][Full Text] [Related]
20. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
